Home / Conditions / Type 1 Diabetes (page 4)

Type 1 Diabetes

Type 1 Diabetes Treatment and Research: Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells. Once called juvenile diabetes, Type 1 is diagnosed most often in children, but can be expressed in adults as well. Incidence is highest among non-hispanic whites, according to the NDEP. Adults with Type 1 make up 5% of all diagnosed diabetes patients.New tools, techniques, treatments, drugs and devices can help you improve outcomes for your patients with Type 1.

Can Bi-Hormonal Systems Finally Eliminate Severe Hypoglycemia?

dual-hormone-artificial-pancreas-severe-hypoglycemia

Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …

Read More »

Why Some Young Adults Lose Diabetes Control After Leaving Pediatric Care

Young adult with type 1 diabetes transitioning from a pediatric diabetes clinic to an adult endocrinology practice, illustrating the challenges of the transition to adult diabetes care.

The transition from pediatric to adult diabetes care is one of the most challenging periods in the lives of young people with diabetes. While many adolescents successfully manage their condition with the support of pediatric diabetes teams, moving into adult healthcare often coincides with worsening blood glucose control, missed appointments, …

Read More »

The Honeymoon Phase Won’t Last Forever: Are We Doing Enough to Preserve Beta Cells?

Hourglass beside a healthy pancreas illustration with insulin syringe and glucose meter representing beta-cell preservation during the type 1 diabetes honeymoon phase.

Receiving a diagnosis of type 1 diabetes can feel overwhelming. Yet for many adults, the weeks or months that follow bring an unexpected twist. Blood glucose levels often become easier to control, insulin needs decrease, and some people wonder if their diabetes is actually improving. This temporary period is known …

Read More »

Teaching Muscles to Make Insulin: Could Gene Therapy Rewrite the Future of Type 1 Diabetes?

3D medical illustration showing skeletal muscle engineered through gene therapy to produce insulin, with DNA strands, gene delivery vectors, and glucose regulation concepts representing future treatment for type 1 diabetes.

For more than a century, insulin therapy has remained the cornerstone of treatment for type 1 diabetes. While continuous glucose monitors, insulin pumps, and automated insulin delivery systems have dramatically improved diabetes management, they still do not replace the body’s natural ability to regulate blood sugar. As a result, researchers …

Read More »

Could a Mini Pancreas Predict Which Diabetes Drug Will Work Best?

Scientist holding a patient-derived pancreatic organoid in a laboratory with a pancreas model and advanced research equipment, illustrating precision diabetes medicine.

Finding the right diabetes medication often involves trial and error. One patient may respond well to a GLP-1 receptor agonist, while another sees little benefit from the same treatment. As a result, clinicians frequently adjust medications before finding the most effective option. What if doctors could test a patient’s response …

Read More »

The Return of C-Peptide: Why This Old Biomarker Is Finding New Clinical Uses

Healthcare professional reviewing C-peptide test results with a pancreatic model, blood sample, and glucose monitoring equipment representing beta-cell function assessment in diabetes care.

For many years, C-peptide testing was viewed as a simple tool to distinguish type 1 diabetes from type 2 diabetes. However, the story has changed. As researchers gain a better understanding of pancreatic beta-cell function, C-peptide testing in diabetes has become much more valuable than a diagnostic aid alone. Today, …

Read More »

The Biotin Blind Spot: How Everyday Supplements Can Skew Critical Diabetes Lab Results

High-dose biotin supplement bottle beside diabetes testing supplies, laboratory blood sample, and thyroid and cardiac lab reports illustrating biotin interference with diagnostic testing.

Biotin supplements have become increasingly popular among people living with diabetes. Many individuals take them to support healthy hair and nails, while others use high-dose formulations in hopes of easing neuropathy symptoms. An often-overlooked concern is biotin interference with laboratory tests used in diabetes care. Although biotin itself does not …

Read More »

Could “Smart” Insulin End Hypoglycemia? The Race Toward Glucose-Responsive Therapy

Illustration of glucose-responsive insulin technology showing a smart insulin vial, syringe, blood glucose monitor, and molecular structures representing glucose-activated insulin therapy.

For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …

Read More »

The Future of Type 1 Screening: Will Genetics Replace Autoantibodies?

Pediatric genetic screening for type 1 diabetes showing a DNA helix, blood sample, and clinical risk assessment used for early detection of disease risk.

Population-based screening for type 1 diabetes is entering a new era. While autoantibody testing remains the gold standard for identifying individuals at high risk, researchers are increasingly investigating whether type 1 diabetes genetic screening could identify susceptible people even earlier. Advances in genomic science now make it possible to estimate …

Read More »